Anitua Eduardo, Allende Mikel, de la Fuente María, Del Fabbro Massimo, Alkhraisat Mohammad Hamdan
Regenerative Medicine Department, BTI Biotechnology Institute, 01007 Vitoria-Gasteiz, Spain.
Clinical Research, University Institute for Regenerative Medicine and Oral Implantology (UIRMI), 01007 Vitoria-Gasteiz, Spain.
Bioengineering (Basel). 2023 Feb 27;10(3):303. doi: 10.3390/bioengineering10030303.
Assisted reproductive technology (ART) is used to enhance pregnancy in infertile women. In this technique, the eggs are removed from the ovary and fertilized and injected with sperm to make embryos. Unfortunately, embryo implantation failures still occur in many of these women. Platelet-rich plasma (PRP) therapies use a patient's own platelets to promote tissue healing and growth, including endometrium. The growth factors provided by the platelets play a criterial role on the regenerative ability of PRP. In the last years, PRP treatments have been gaining a lot of popularity to treat women with repeated ART failures. In this study, we collected and summarized all information published in the scientific literature to assess the evidence of the PRP effect on pregnancy. We only considered randomized controlled trials (RCT), a type of study designed to be unbiased and considered at the highest level of evidence. Our analysis indicates that PRP therapies might be an effective treatment in cases of poor responsiveness to conventional ART. However, additional studies (well-designed) are necessary to confirm this beneficial effect of PRP.
辅助生殖技术(ART)用于提高不孕女性的受孕几率。在这项技术中,卵子从卵巢中取出,进行受精并注入精子以形成胚胎。不幸的是,许多接受此类治疗的女性仍会出现胚胎着床失败的情况。富含血小板血浆(PRP)疗法利用患者自身的血小板来促进包括子宫内膜在内的组织愈合和生长。血小板提供的生长因子对PRP的再生能力起着关键作用。近年来,PRP治疗在治疗反复ART失败的女性中越来越受欢迎。在本研究中,我们收集并总结了科学文献中发表的所有信息,以评估PRP对妊娠影响的证据。我们仅考虑随机对照试验(RCT),这是一种旨在确保无偏性且被视为最高证据水平的研究类型。我们的分析表明,PRP疗法在对传统ART反应不佳的情况下可能是一种有效的治疗方法。然而,需要更多(设计良好的)研究来证实PRP的这种有益效果。